Anthem Biosciences Ltd
NSE: ANTHEM BSE: 544449
₹769.10
(1.46%)
Tue, 26 May 2026, 06:26 pm
Market Cap438.28B
PE Ratio73.54
Dividend0
Health Technology
Biotechnology
24.5KAnthem Biosciences Income Statement
| Particulars | 2021 | 2022 | 2023 |
|---|---|---|---|
| Total revenue | 12.31B | 10.57B | 14.19B |
| Gross profit | 5.79B | 4.49B | 5.06B |
| Operating expenses (excl. COGS) | -697.30M | -770.98M | -724.94M |
| Selling/general/admin expenses, total | -645.52M | -706.85M | -682.11M |
| Research & development | -247.88M | -258.61M | -231.61M |
| Selling/general/admin expenses, other | -397.64M | -448.24M | -450.50M |
| Other operating expenses, total | -51.78M | -64.13M | -42.83M |
| Operating income | 5.09B | 3.72B | 4.33B |
| Non-operating income, total | 373.02M | 1.26B | 440.58M |
| Interest expense, net of interest capitalized | -100.86M | -67.63M | -95.35M |
| Interest capitalized | 0 | 0 | 0 |
| Non-operating income, excl. interest expenses | 436.79M | 790.08M | 544.03M |
| Non-operating interest income | 95.76M | 290.99M | 408.62M |
| Miscellaneous non-operating expense | 329.45M | 489.28M | 131.00M |
| Unusual income/expense | 37.09M | 533.62M | -8.10M |
| Pretax income | 5.46B | 4.97B | 4.77B |
| Taxes | -1.41B | -1.12B | -1.10B |
| Non-controlling/minority interest | 0 | 0 | 0 |
| After tax other income/expense | 0 | 0 | 0 |
| Net income before discontinued operations | 4.06B | 3.85B | 3.67B |
| Net income | 4.06B | 3.85B | 3.67B |
| Dilution adjustment | 0 | 0 | 0 |
| Preferred dividends | 0 | 0 | 0 |
| Diluted net income available to common stockholders | 4.06B | 3.85B | 3.67B |
| Basic earnings per share (Basic EPS) | - | - | - |
| Diluted earnings per share (Diluted EPS) | - | - | - |
| EBITDA | 5.67B | 4.35B | 5.15B |
| EBIT | 5.09B | 3.72B | 4.33B |
| Total operating expenses | -7.22B | -6.85B | -9.86B |
| Prepaid expenses | 25.04M | 19.43M | 31.67M |
| Deferred income, current | 578.91M | 14.00M | 337.67M |
| Capital and operating lease obligations | 11.32M | 7.64M | 43.06M |
| Operating lease liabilities | — | — | — |
| Deferred tax liabilities | — | — | — |
| Deferred income, non-current | — | — | — |
| Minority interest | 0 | 0 | 0 |
| Change in accrued expenses | — | — | — |
| Common dividends paid | -10.00K | 0 | 0 |
| Preferred dividends paid | 0 | 0 | 0 |